Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-07-16 | New | $4,216,794 | $4,216,794 | Equity Only | 06b | SEC link |
| 2025-01-22 | New | $7,103,000 | $7,103,000 | Equity Only | 06b | SEC link |
| 2023-12-14 | New | $700,000 | $700,000 | Other | 06b | SEC link |
| 2023-01-11 | New | $2,000,000 | $2,000,000 | Equity Only | 06b | SEC link |
| 2021-09-01 | New | $1,000,000 | Unknown | Debt Only | SEC link | |
| 2020-05-01 | New | Yet to Sell | $0 | Debt Only | 06b | SEC link |
| 2019-12-05 | New | $359,000 | $359,000 | Other | 06b | SEC link |
| Name | Role |
|---|---|
| Christopher P. Acevedo | Executive |
| Joacim Borg | Director |
| John Ciccio | Director |
| Gerald Commissiong | Executive |
| Karim Galzahr | Director |
| Colin Goddard | Director |
| Olivier Jarry | Director |
| Avril Mc Kean Dieser | Director |
| Robert G. Petit | Executive |
| Paul A. Romness | Director, Executive |
| Theodore F. Search | Director |
| Jutta Wanner | Executive |